/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

R

Rohitha Sriramaratnam

Jnana Therapeutics (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

18

Papers

7.5K

Citations

8

h-index

8

i10-index

Rohitha Sriramaratnam is an academic researcher from Jnana Therapeutics (United States). The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Click Chemistry and Applications & Ubiquitin and proteasome pathways. The author has an h-index of 8, co-authored 16 publications.

ORCID: 0000-0001-5252-8104

Research Topics

PI3K/AKT/mTOR signaling in cancer Click Chemistry and Applications Ubiquitin and proteasome pathways Protein Degradation and Inhibitors Advanced Breast Cancer Therapies

Papers by this author

works

Regulation of Ferroptotic Cancer Cell Death by GPX4

2014 · Cell · 7,087 citations

https://doi.org/10.1016/j.cell.2013.12.010

Wan Seok Yang Rohitha Sriramaratnam Matthew Welsch Kaoru Shimada

Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα

2022 · Journal of the American Chemical Society · 52 citations

https://doi.org/10.1021/jacs.1c13568

Chiara Borsari Erhan Keleş Jacob A. McPhail Alexander Schaefer

Research topics

topics

PI3K/AKT/mTOR signaling in cancer

Click Chemistry and Applications

Ubiquitin and proteasome pathways

Protein Degradation and Inhibitors

Advanced Breast Cancer Therapies

Chat about Author

Papers

Chat

Click to start Chat